SAVANNAH Phase II trial demonstrated high and durable response rates with savolitinib plus TAGRISSO ® in MET-high lung cancer, representing a promising chemo-free oral treatm ...
Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback